Regular seeds have a male to female ratio of about 50%. Once the plant shows sign of sex, the males are usually removed so that your cannabis flowers have no seeds and higher levels of cannabinoids.
Feminized seeds will almost always produce female plants, but is not 100% and may not produce as high of a yield as "regular" seeds. Plant sex still needs to be checked.
Auto-flowering seeds are hybrids that have been crossed with Ruderalis. They will automatically start to flower regardless of light hours and usually finish fast but have some of the lowest yields.
Indica strains tend to be shorter and bushier then Sativa strains. They are usually used later in the day as they tend to make people tired. Some of the things Indicas can be used for is anxiety, pain management and sleeping disorders.
Sativa strains tend to grow taller then Indica strains. They can grow to heights higher then 20 feet. Sativas tend to be used during they day because can increase alertness and creativity. Some of the things that Sativas can be used for is ADHD, anxiety, pain management, and fatigue.
Hybrid strains have a mix of Indica, Sativa and sometimes Ruderalis. Seeds can be more dominate in one species or the other and offer a balance of the attributes between them.
Across the world many people enjoy cannabis privately or socially in groups. Cannabis can help create a wonderful mood where people can enjoy food, interesting conversations, and the things that bring bouts of unstoppable giggles.
The cat is finally out of the bag. The great race is on to patent the next synthetic cannabinoid. Lucky for us, people have been taking care of themselves in this aspect for a hundred years and now you can keep more of your money.
Chronic pain is a good example for cannabis. Muscles are tense, nerve is inflamed, might be depressed and be anxious. Cannabis helps on multiple fronts by relaxing muscles, allays anxiety, elevates mood, diverts attention away from pain and directly targets pain receptors to effectively help break the pain cycle.
Cannabis and its derivatives could be useful in the treatments of alzheimer's, arthritis, anxiety, anorexia, ADHD, back / neck problems, bipolar disorder, cancer, colitis, cramps, crohn's disease, dementia, depression, eating disorders, epilepsy, fibromyalgia, fatigue, gastrointestinal disorder, glaucoma, lack of appetite, headaches, hepatitis C, HIV / AIDS, inflammation, insomnia, nausea, migraines, muscular dystrophy, muscle spasms, multiple sclerosis, parkinson's disease, PTSD, PMS, pain, phantom limb pain, sleep disorders, stress, spasm, seizures, spinal cord injury, tourette's syndrome and more are being discovered all the time.
No, there are many ways to enjoy cannabis and the affects without smoking. The lungs are the fastest way into your body but you can take sublingual doses that will effect you in minutes instead of seconds.
With the loosening of restraints on cannabis research there is now moderate evidence of no statistical association between smoking cannabis and cancers of the lungs, neck or head.
The fact that the cannabis plants cannabinoids fit our own endocannabinoid system like a key in a lock is amazing. Our bodies make natural cannabinoids that are even found in breast milk. Cannabinoid receptors out number any other in our body. The possibilities for cannabis are only limited by our imagination. Read more in our Endocannabinoid System section.
Cannabis seeds have been around for 25 million years and cannabis has been used for thousands of years therapeutically in recorded history. Now we are starting down a path of scientific understanding of how it effects health, wellness, cancer, dementia, and other ailments.
The discovery of THC has been widely attributed to Israeli researcher Raphael Mechoulam in 1964 but there is also information to support the idea that American organic chemist Roger Adams discovered it in 1940.
In 1988 American researcher Allyn Howlett and her graduate student William Devane discovered the first cannabinoid receptors in the brain and named it Cannabinoid 1 receptors (CB1).
In 1992 researchers in Isreal found an endogenous cannabinoid and called it N-arahidonoyl ethanolamine or anandamide.
In 1993 scientists found cannabinoid receptors in the immune system (CB2), and subsequently discovered a second endocannabinoid called 2-arachidonoyl glycerol.
So far there have been five endocannabinoids discovered with the first two, anandamide and 2-AG appearing to have the most importance. Scientists have realized that CB1 receptors are found mostly in the spinal cord, brain and peripheral nervous system. This very reason explains the role of cannabinoids in pain modulation, memory processing and motor control. CB2 receptors are located mainly in immune cells such as the spleen and tonsils.
The human body has more receptors for cannabinoids than for any other substance. The human body makes its own versions of the cannabinoids found in cannabis plants called "endocannabinoids".
Endocannabinoids help regulate almost all brain and body processes, pain perception, appetite control, tempature regulation, regeneration, healing, inflammation, multiple other functions and is also found in breast milk.
Cannabis has an amazing side effect profile. No one has ever died directly from a lethal dose of cannabis. The lethal dose is so huge that it can not be administered or consumed in one single setting in a human being.
The safeness of cannabis comes from the fact that receptors are scarce on the brain stem where the cardiac and respiratory system resides.
For example, narcotic analgesics like Vicodin and Percocet have opioid receptors in abundance in the brain stem. If you were to take to much of these or similar drugs your cardiac and respiratory system function goes down leading to respiratory arrest or death.
The endocannabinoid system is one of the most interesting systems found in the human body. As more is learned about the endocannabinoid system a greater interest in its therapeutic value will emerge. The many side effects of opiate based medicines have become too burdensome for many people. It is likely in the coming years that pharmaceutical companies will exploit the many medical applications that cannabinoids can be prescribed for.
Several decades of research has led to a better understanding how cannabinoids help regulate homeostasis. Scientists are harnessing the therapeutic effects of its main mind altering ingredient THC and are finding useful constituents such as CBD or Cannabidiol.
Some of the things CB receptors help with:
CB1 receptors help with anxiety, stress, increasing euphoria and feelings of happiness, decrease in convulsions and tremors and coping with chronic pain.
CB2 receptors help by decreasing cancer cells, boosting immune system and coping with alzheimer's disease.
CB receptors are also found on our skin, this explains why topical cannabis applications if properly prepared can have a profound effect on the human body.
There are about 60 cannabinoids and up to 400 compounds in cannabis that have multiple actions with many still unexplained. This makes cannabis a versatile therapeutic tool.
Cannabis targets the spirit, mind and body. An example would be chronic pain, muscles are tense, nerve is inflamed, might be depressed or anxious from pain. Cannabis targets all of those facets in different ways. First it relaxes the muscles, calms anxiety, elevates mood, diverts attention from pain and directly targets pain receptors. It breaks the pain cycle so you can rest at ease.
Cannabinoid receptors have been found in central nucleus of the amygdala which processes painful and traumatic memories and helps extinguish some of these memories so we can move on.
If you are taking opiates or NSAIDs, the right strain of cannabis will reduce the need for them as much or completely.
The addictive potential of cannabis is minimal, after longterm heavy daily use of cannabis only 10 percent of people become addicted. The withdrawal after years of of heavy use is based on a short duration of irritability and insomnia. Which is mild when compared to opiates and similar pain drugs.
February 8, 2018 here.
February 26, 2018 here.
March 1, 2018 here.
April 25, 2018 here.
May 7, 2018 here.
May 9, 2018 here.
May 22, 2018 here.
June 1, 2018 here.
June 4, 2018 here.
June 6, 2018 here.
The Senate of Canada has passed Bill C-45, the Cannabis Act, as amended, at third reading. The House of Commons must now consider the Senate’s amendments.
Bill C-45 is a piece of government legislation that would legalize access to cannabis in Canada. The bill would also control and regulate how cannabis is grown, distributed and sold.
Bill C-45 was introduced in the Senate and given first reading on November 28, 2017. It was passed in the House of Commons on November 27, 2017.
Bill C-45 was adopted at second reading in the Senate on March 22, 2018 and was referred to the Senate Committee on Social Affairs, Science and Technology.
The committee’s report, with amendments to the bill, was adopted on division on May 30, 2018.
On May 31, 2018, debate began at third reading. Pursuant to a motion adopted in the Chamber, speeches and amendments were being grouped thematically:
The vote at third reading took place on June 7, 2018. Bill C-45 was adopted by a vote of 56 to 30, with one abstention.